Search

CATIE resources, guidelines, position papers and consensus statements

Parts of this U=U Guide draw on materials from: Prevention Access Campaign1 Gay Men’s Sexual Health Alliance of Ontario (GMSH): U=U Position Statement2 ...

Canadian study finds cervical cancer screening delayed in 30% of women with HIV. Pap tests are recommended on an annual basis for HIV-positive women in Canada. ...

Anti-HIV Agents

Biktarvy is a pill containing the following three medicines: . bictegravir (an integrase inhibitor). TAF (tenofovir alafenamide; the safer formulation of ...

In late August 2019, a pill called Dovato (containing dolutegravir + 3TC) was approved for the treatment of HIV in Canada and other high-income countries. The ...

The dual-drug regimen dolutegravir + 3TC, sold in a pill called Dovato, has been approved in Canada and other high-income countries for the treatment of HIV ...

The clinical trials for Dovato (a combination of dolutegravir and 3TC) for the initial treatment of HIV or for a change to a simpler regimen have found this ...

The pharmaceutical company ViiV Healthcare has been the leader in developing potent dual-drug HIV regimens, such as the following: . Juluca – a pill ...

Dolutegravir belongs to a class of anti-HIV drugs called integrase inhibitors. In Canada and other high-income countries, dolutegravir is sold in the following ...

Scientists conducted a randomized study of ketamine and mindfulness. Results appear promising as some people were able to stop using cocaine. More research lies ...

Scientists in B.C. mapped the flow of patients from hepatitis C diagnosis to cure. At each stage of the cascade, some patients did not progress to the next step ...